8-K//Current report
PhaseBio Pharmaceuticals Inc 8-K
Accession 0001193125-24-140615
CIK 0001169245operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:28 PM ET
Size
3.3 MB
Accession
0001193125-24-140615
Documents
- 8-Kd819924d8k.htmPrimary
8-K
- EX-99.1d819924dex991.htm
EX-99.1
- EX-99.2d819924dex992.htm
EX-99.2
- EX-101.SCHphasq-20240322.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABphasq-20240322_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREphasq-20240322_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICg819924sp14.jpg
GRAPHIC
- GRAPHICg819924sp15.jpg
GRAPHIC
- GRAPHICg819924sp16.jpg
GRAPHIC
- GRAPHICg819924sp33.jpg
GRAPHIC
- GRAPHICg819924sp34.jpg
GRAPHIC
- GRAPHICg819924sp35.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-24-140615-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd819924d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001169245
Filing Metadata
- Form type
- 8-K
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:28 PM ET
- Size
- 3.3 MB